Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Á÷Àå¾ÏÀÇ ¼ö¼úÈÄ ¹æ»ç¼±Ä¡·á¼ºÀû The Results of Postoperative Radiation Therapy in the Rectal Cancer

´ëÇѾÏÇÐȸÁö 1997³â 29±Ç 1È£ p.111 ~ 116
¼Ò¼Ó »ó¼¼Á¤º¸
À¯¹Ì·É/Mi Ryeong Ryu ÀåÈ«¼®/À±¼¼Ã¶/Á¤¼ö¹Ì/±è¿¬½Ç/±è¼¼°æ/±èÀÎö/½Å°æ¼·/Hong Seok Jang/Sei Chul Yoon/Su Mi Chung/Yeon Shil Kim/Se Kyung Kim/In Chul Kim/Kyung Sub Shinn

Abstract

°á·Ð
1984³â¿¡¼­ 1993³â±îÁö °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ °­³²¼º¸ðº´¿ø Ä¡·á¹æ»ç¼±°ú¿¡¼­ ±ÙÄ¡Àû ¼ö
¼ú ÈÄ ¹æ»ç¼±Ä¡·á¸¦ ¹ÞÀº 70¸íÀÇ Á÷Àå¾Ï ȯÀÚ¸¦ ´ë»óÀ¸·Î ÃßÀûÁ¶»ç°¡ °¡´ÉÇÑ 64¸í¿¡ ´ëÇÑ
¼ºÀûºÐ¼® °á°ú ´ÙÀ½°ú °°Àº °á·ÐÀ» ¾ò¾ú´Ù
1) Àüü ȯÀÚÀÇ 2³â ¹× 5³â »ýÁ¸À²Àº 70.3%, 51.4%¿´°í, º´±â B2+3Àº 90.9%,
90.9%, º´±â C´Â 68.2%, 53.6%·Î º´±â°£ÀÇ »ýÁ¸À²ÀÇ Â÷ÀÌ°¡ Åë°èÇÐÀûÀ¸·Î À¯ÀÇÇÏ¿´´Ù
(P<0.05).
2) Àüü ȯÀÚÀÇ 2³â ¹× 5³â ¹«º´»ýÁ¸À²Àº 63.1%, 48.5%¿´´Ù.
3) ±¹¼Ò½ÇÆÐÀ²Àº Àüü ȯÀÚÀÇ 20.3%¿´À¸¸ç Àüõ°ñ°­ÀÌ °¡Àå ¸¹¾Ò´Ù
4) ¿ø°ÝÀüÀÌÀ²Àº ÀüüȯÀÚÀÇ 18.7%¿´À¸¸ç °£ÀÌ °¡Àå ¸¹¾Ò´Ù.
5) ÇÕº´ÁõÀº ¼ö¼úÀ» ¿äÇÏ´Â ¼ÒÀåÆó»öÁõÀÌ 3¿¹(5%)¿¡¼­ ³ªÅ¸³µÀ¸³ª Ä¡¸íÀûÀÎ ¿¹´Â ¾ø¾ú´Ù.
6) ¿¹ÈÄÀÎÀڷδ º´±â(P=0.0019)¿Í Á¶Á÷ÇÐÀû ºÐÈ­Á¤µµ(P=0.0046)°¡ Åë°èÇÐÀûÀ¸·Î À¯ÀÇÇÏ°Ô
³ªÅ¸³µ´Ù.
#ÃÊ·Ï#
Purpose : This study was designed to evaluate the prognostic factors, survival rate
and local recurrence rate of the patients with rectal cancer who received postoperative
radia- tion therapy.
Methods & Materials : Seventy patients with rectal cancer received postoperative
radiation therapy after curative surgery at the Department of Therapeutic Radiology,
Kangnam St. Mary's Hospital, Catholic University Medial College between May 1984
and April 1993. Of the seventy patients, sixty-four evaluable patients were analysed
retrospectively. There were 34 men and 28 women. Age at diagnosis ranged from 23 to
74 years. The distribution of stage according to the modified Astler-Coiler(MAC) system
was as follow: 12 in B2+3 in C1, and 50 in C
2+3
. Postoperative adjuvant therapy included pelvic radiotherapy in all cases and
chemotherapy in addition in 55 cases.4 total dose of 45 to 60 Gy(median dose: 55.8Gy)
was delivered in a period of 5 to 6 weeks and the follow-up period ranged from 26 to
133 months with a median of 55 months.
Results : Overall two-year and five-year actuarial survival rate were 70.3% and
51.4%, 90.9% and 90.9% in stage B2.3, and 68.2% and 53.6% in stage C. Local failure
occurred in 13(20.3%) of the'64 patients and distant failure rate was 18.8%(12/64).
Severe late complication was small bowel obstruction in 4 patients and surgery was
required in 3 patients(5%). The significant prognostic factors were stage(p=0.0019) and
histologic differentiation (p=0.0046).
Conclusion : This study suggested a potential adjuvant role for radiation. However,
the possible reduction in local failure rates in this study compared with historic control
groups must be verified in randomized trial.

Å°¿öµå

Rectal cancer; Postoperative radiation therapy;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS